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Introduction
Quality of life is defined as “individuals perception of their po-
sition in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, stand-
ards and concerns” (World Health Organization 1998). Thus, 
quality of life in medicine involves physical, mental and social 
well-being, as well as patients’ ability to perform everyday tasks.
Over the last decades, considerable efforts have been made to 
develop dedicated quality of life assessment in patients with 
epilepsy and to assess the impact of demographic, clinical, 
psychosocial factors and epilepsy-associated comorbidities on 
quality of life.
Although there are numerous studies assessing quality of life of 
people with epilepsy worldwide, similar studies have not been 
found for our country. It is necessary to determine the extent 
of the problem as part of the systematic approach in the man-
agement of epilepsy.
Materials and methods
There was a total number of 113 patients enrolled in the study, 
evaluated between 1 March 2008 ans 31 March 2010 in the 
Clinic of Neurology, Cluj-Napoca, presenting idiopathic epi-
lepsy (genetic), structural-metabolic epilepsy or epilepsy of 
unknown cause with mono or polytherapy. Patients enrolled in 
the study had a stable treatment scheme for at least one month 
prior to the study.
Based on customized questionnaires, complex demographic data 
and clinical parameters were collected: age, disease duration, 
gender, education, employment status, financial situation, type 
of epilepsy, etiological factors, type of seizures, number of sei-
zures (during the last month and the last year, respectively), an-
tiepileptic drugs (AED) administered.
Patients had to fill in the questionnaire on quality of life in epi-
lepsy (QOLIE-31). The questionnaire on quality of life in pa-
tients with epilepsy (QOLIE-31) consists of seven scales cov-
ering the following concepts of health: emotional well-being, 
overall quality of life, social functioning, energy/fatigue, cogni-
tive functioning, seizure worry and medication effects.
The score corresponding to each scale as well as QOLIE-31 to-
tal score was calculated for each patient.
MedCalc software version 12.7 was used for statistical analysis.
Data were organized as categorical and quantitative variables. 
Categorical variables were characterized by frequencies and per-
centages. Kolmogorov-Smirnov test was used to determine the 
normality of the distribution of quantitative variables. Quantitative 
variables with normal distribution were described using mean 
and standard deviation, and those with non-normal distribution 
were described using median, 25th and 75th percentiles. The 
analysis of the differences in variables with normal distribution 
between two different groups was performed using the T test for 
independent variables, while Mann-Whitney test was employed 
for variables with non-normal distribution. Analysis of variance 
and Tukey posthoc analysis were used to analyze the differences 
in quantitative variables between three groups. Depending on 
the situation, Pearson’s correlation or Spearman’s correlation 
was used for the analysis of two continuous variables.
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Chi-squared test (χ2) was used for univariate analysis of cat-
egorical variables.
A p-value of 0.05 was set as level of statistical significance.
Results
Patients in the study were aged between 18 and 70 years, with 
a median age of 33 (25.5, 49) years.
The study consisted of 72 (63.7%) female patients and 41 (36.3%) 
male patients. There were no significant differences in patient 
age depending on gender (p=0.3) .
Overall quality of life score (with non-normal distribution) had 
a median value of 9.4 (6.4, 11.5), a minimum value of 1.8 and 
a maximum value of 14.
We determined the existence of a negative correlation of av-
erage statistical significance between age and cognitive func-
tioning scale score (r=-0.3, p=0.001), overall quality of life 
scale score (r=-0.32, p=0.001) and of low statistically signifi-
cant correlations between age and emotional well-being scale 
score (r=-0.245, p=0.009), social functioning score (r=-0.212, 
p=0.02) and QOLIE-31 total score (r=-0.29, p=0.002). There 
were no statistically significant correlations between age and 
other QOLIE scales (p> 0,05).
There were no differences in QOLIE-31 total score based on 
patient gender (p>0,05).
The study included 41 (32.7%) subjects with unknown marital 
status, 35 (31%) married and 37 (32.6%) unmarried or divorced 
individuals. There were no statistically significant differences in 
QOLIE scale scores based on marital status (p>0,05).
The study included 18 (15.9%) patients without a job, 68 (60.2%) 
patients with a job and 27 (23.9%) retired patients (because of 
age or disease).
Score values related to emotional well-being, energy/fatigue, 
cognitive functioning, social functioning and QOLIE-31 total 
score were statistically significantly different depending on the 
degree of employment of epileptic patients (p<0,05). Tukey’s 
post hoc analysis revealed the groups of professions that showed 
statistically significant differences (Table 1).
The study included 14 (12.4%) patients with primary education 
(maximum 8 years of study), 52 (46%) patients with second-
ary education and 47 (41.6%) patients with higher education.
Thirty-four (30.1%) patients revealed an unsatisfactory finan-
cial situation, 37 (32.7%) subjects an average financial situa-
tion, and 42 (37.2%) patients had a better financial situation. 
Overall quality of life, emotional well-being, energy/fatigue, 
cognitive functioning, medication effects, social functioning 
and QOLIE-31 total score values were statistically significantly 
different depending on the financial situation of epileptic pa-
tients (p<0, 05). Tukey’s post hoc analysis indicated the finan-
cial situations determining statistically significant differences 
in QOLIE-31 questionnaire scales (Table 3).
There were no significant correlations between age of onset of 
epilepsy and QOLIE scores (p>0.05). We demonstrated a nega-
tive correlation of low statistical significance between disease 
age and overall quality of life score (r=-0.23, p=0.01), energy/
fatigue score (r=-0.194, p=0.04), cognitive functioning score 
(r=-0.206, p=0.02) and QOLIE-31 total score (r=-0.224, p=0.01).
We demonstrated the existence of a negative correlation of high 
statistical significance between the yearly number of seizures 
and social functioning score (r=-0.533, p< 0.001). We found a 
negative correlation of average statistical significance between 
the yearly number of seizures and overall quality of life score 
(r=-0.352, p=0.001), cognitive functioning (r=-0.37, p<0.001) 
and QOLIE-31 total score (r=-0.454, p< 0.001). We determined 
the existence of a negative correlation of low statistical signifi-
cance between the yearly number of seizures and the seizures 
worry (r=-0.252, p=0.01), emotional well-being (r=-0.259, 
p=0.01), energy/fatigue score (r=-0.288, p=0.005) and medi-
cation effects score (r=-0.229, p=0.02).
Table 1. Correlations between employment and QOLIE scales
There were no significant correlations between age of onset of 
epilepsy and QOLIE scores (p>0.05). We demonstrated a nega-
tive correlation of low statistical significance between disease 
age and overall quality of life score (r=-0.23, p=0.01), energy/
fatigue score (r=-0.194, p=0.04), cognitive functioning score 
(r=-0.206, p=0.02) and QOLIE-31 total score (r=-0.224, p=0.01).
We demonstrated the existence of a negative correlation of high 
statistical significance between the yearly number of seizures 
and social functioning score (r=-0.533, p< 0.001). We found a 
negative correlation of average statistical significance between 
the yearly number of seizures and overall quality of life score 
(r=-0.352, p=0.001), cognitive functioning (r=-0.37, p<0.001) 
and QOLIE-31 total score (r=-0.454, p< 0.001). We determined 
the existence of a negative correlation of low statistical signifi-
cance between the yearly number of seizures and the seizures 
worry (r=-0.252, p=0.01), emotional well-being (r=-0.259, 
p=0.01), energy/fatigue score (r=-0.288, p=0.005) and medi-
cation effects score (r=-0.229, p=0.02).
Variable
(I) 
Profession
(J) 
Profession
Difference 
(I-J)
p
Emotional 
well-being
Without 
job
With job -1.9 0.09
Retired 0.2 0.9
With job
Without job 1.9 0.09
Retired 2.1 0.01
Energy/
fatigue
Without 
job
With job -1.3 0.1
Retired 0.2 0.9
With job
Without job 1.3 0.1
Retired 1.6 0.02
Cognitive 
functioning
Without 
job
With job -7.6 <0.001
Retired 0.1 0.9
With job
Without job 7.6 <0.001
Retired 7.7 <0.001
Social 
functioning
Without 
job
With job -4 0.009
Retired -1.2 0.7
With job
Without job 4 0.009
Retired 2.7 0.03
QOLIE-31 
total score
Without 
job
With job -16.8 0.002
Retired -0.5 0.9
With job
Without job 16.8 0.002
Retired 16.2 <0.001Brusturean-Bota et al 2013
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The study included 45 (39.8%) patients with more than one epi-
leptic seizure per month. Patients with more than one seizure 
per month had lower values (of high statistical significance) of 
overall quality of life score compared to (8.4 (6.3, 10.1)) patients 
with controlled seizures (10.8 (8.4, 11.5)) (p<0.001). The cor-
relations between the monthly frequency of epileptic seizures 
and QOLIE scores are shown in Table 4.
The study consisted of 43 (38.1%) patients with focal-onset sei-
zures, 51 (45.1%) patients with generalized-onset tonic-clonic 
seizures, 3 (2.7%) patients with absences, 6 (5.3%) patients with 
myoclonus, 1 (0.9%) patient with atonic seizures and 9 (8%) pa-
tients with focal-onset seizures secondarily generalized. There 
were no differences in QOLIE scale scores between different 
types of epileptic seizures (p>0.05).
Table 2. Correlations between level of education and QOLIE scales
A number of 60 (53.1%) patients were diagnosed with idiopathic 
epilepsy, while 39 (34.5%) were diagnosed with symptomatic 
epilepsy and 14 (12.4%) with cryptogenic epilepsy (of unknown 
cause). There were no significant associations between the eti-
ological type of epilepsy and QOLIE score values (p>0.05).
The score related to the effects of medication was significantly 
higher in patients who were treated with VPS (1.9 ± 0.7) com-
pared to those without this therapy (1.5 ± 0.8) (p=0.03). Social 
functioning score was lower in patients treated with CBZ (12 ± 
5.4) compared to those without this therapy (14 ± 4.6) (p=0,04). 
Socializing score and QOLIE-31 total score were lower in pa-
tients treated with PTH (12 ± 5.4, 49.1 ± 18.6 respectively) 
compared to those without this therapy (14 ± 4, 6, 59.8 ± 18.8 
respectively) (p=0.03, p=0.05 respectively). Social functioning 
score was lower in patients treated with PB (10.7 ± 4.4) com-
pared to those without this therapy (13.8 ± 5) (p=0.008). The 
score related to medication effects was lower in patients treated 
with TPM (11.5 ± 5.5) compared to those without this therapy 
(13.3 ± 5) (p=0.04).
Table 4. Correlations between the frequency of epileptic sei-
zures per month and QOLIE-31 scale scores
Discussions
Patients suffering from epilepsy tend to have a lower quality of 
life. Generally, there are more unemployed individuals among 
these patients, with poorer financial situation and lower mar-
riage rates, facing social isolation.
The main objective of this study was to determine the impact 
of various clinical, social and demographic factors on qual-
ity of life in patients with epilepsy monitored at the Clinic of 
Neurology, Cluj-Napoca.
The median age of the study population was 33 years, without 
significant differences in patient age based on gender.
This study demonstrates that patient age had a negative impact 
on the cognitive function and overall quality of life, as well 
Variable
(I) Level of 
education
(J) 
Level of 
education
Mean 
difference 
(I-J)
p
Overall 
quality of life
Primary
Secondary -0.8 0.464
Higher -2.2 0.01
Secondary 
Primary 0.8 0.464
Higher -1.3 0.021
Emotional 
well-being
Primary
Secondary -2 0.062
Higher -3.7 <0.001
Secondary
Primary 2 0.062
Higher -1.6 0.02
Energy/fatigue
Primary
Secondary -1.1 0.296
Higher -2.2 0.011
Secondary
Primary 1.1 0.296
Higher -1.1 0.078
Cognitive 
functioning
Primary
Secondary -6.6 0.005
Higher -10.8 <0.001
Secondary
 Primary 6.6 0.005
Higher -4.1 0.011
Medication 
effects
Primary
Secondary 0 0.922
Higher -0.4 0.161
Secondary
Primary 0 0.922
Higher -0.5 0.003
Social 
functioning
Primary
Secondary -1.4 0.564
Higher -4.4 0.008
Secondary
Primary 1.4 0.564
Higher -2.9 0.007
QOLIE total 
score
Primary
Secondary -12.4 0.046
Higher -24.8  <0.001
Secondary
Primary 12.4 0.046
Higher -12.4 0.001
Variable
>1 seizure/
month
Mean SD p
Seizure worry
No 3.8 2
<0.001
Yes 2.4 1.6
Emotional 
well-being
No 9.9 3.4
0.004
Yes 8 3
Energy/
fatigue
No 7.3 2.6
0.001
Yes 5.5 2.2
Cognitive 
functioning
No 18.2 7.2
<0.001
Yes 12.3 6.6
Medication 
effects
No 1.8 0.8
0.002
Yes 1.4 0.8
Social 
functioning
No 15.4 4.4
<0.001
Yes 10.7 4.2
QOLIE-31 
total score
No 66.7 18.1
<0.001
Yes 48,8 15Brusturean-Bota et al 2013
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as on emotional state, socializing and QOLIE-31 total score. 
Similar correlations between age and QOLIE total score were 
reported in most of the studies in this field (Miller et al 2003;   
Szaflarski et al 2006; Giray et al 2009; Edefonti et al 2011). In 
the study “Quality of Life in Patients with epilepsy in India”, 
the authors reported no correlation between age and QOLIE to-
tal score, but they did report negative correlations between age 
and emotional state (Shetty et al 2011). Data from other stud-
ies suggest that age does not exert negative correlations with 
QOLIE total score (Baker et al 2001; Canuet et al 2009). In the 
study conducted by Luoni et al and in previous reports, older 
age tended to be negatively correlated with QOLIE total score, 
with cognitive function, energy/fatigue score and medication 
effects (Djibouti 2003; Luoni et al 2011). Our results show that 
age does not significantly affect energy/fatigue and medication 
effects scale scores or the fear of the occurrence of new seizures.
There were no differences in QOLIE-31 total score depending 
on patient gender (p>0.05). Other authors have reported dif-
ferences in this respect, with the female population presenting 
a significantly lower QOLIE total score than the male popula-
tion (Shetty et al 2011). In a study conducted in Georgia, female 
patients had significantly lower scores in terms of the fear of 
developing new seizures (Djibouti 2003). Similar results were 
found in a study conducted by Buck, showing low scores of en-
ergy/fatigue and overall quality of life scores in women from 15 
European countries. These women came from both developed 
countries and countries in economic transition. This may indi-
cate that biological and psychological factors (family issues, 
personal life, motherhood) may play a more important role than 
socioeconomic factors and the availability and access to health 
services. Therefore, future studies need to find the reason for this 
lower quality of life in women with epilepsy (Buck et al 1999).
Many reports suggest that there is a lower marriage rate in in-
dividuals with epilepsy compared to the general population 
(Baker et al 1997). Myeong-Kyu Kim studied marital status in 
Asian patients with epilepsy and reported high divorce rates in 
these patients (Kim 2007). An Indian study reported statistically 
significantly lower scores for energy, emotional instability and 
Variable (I) Financial situation (J) Financial situation Difference (I-J) p
Overall quality of life 
Unsatisfactory
Average -1.1 0.1
Good -1.9 0.003
Average
Unsatisfactory 1.1 0.1
Good -0.7 0.3
Emotional well-being
Unsatisfactory
Average -2 0.01
Good -3.1 <0.001
Average
Unsatisfactory 2 0.01
Good -1 0.2
Energy/fatigue
Unsatisfactory
Average -1.6 0.01
Good -2.3 <0.001
Average
Unsatisfactory 1.6 0.01
Good -0.6 0.4
Cognitive functioning
Unsatisfactory
Average -4.3 0.02
Good -8.1 <0.001
Average
Unsatisfactory 4.3 0.02
Good -3.7 0.05
Medication effects
Unsatisfactory
Average 0.2 0.4
Good -0.2 0.4
Average
Unsatisfactory -0.2 0.4
Good -0.4 0.03
Social functioning
Unsatisfactory
Average -0.7 0.7
Good -3.9 0.001
Average
Unsatisfactory 0.7 0.7
Good -3.1 0.01
QOLIE-31 total score
Unsatisfactory
Average -10.2 0.03
Good -20.3 <0.001
Average
Unsatisfactory 10.2 0.03
Good -10 0.02
Table 3. Correlations between financial situation and QOLIE scalesBrusturean-Bota et al 2013
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social isolation in married patients with epilepsy (Shetty et al 
2011). In the present study, there were no statistically signifi-
cant differences in QOLIE scale scores based on marital sta-
tus (p> 0,05).
This study included 18 (15.9%) patients without job (unem-
ployed), 68 (60.2%) patients with job (employed) and 27 (23.9%) 
patients retired because of age or disease. Other studies have 
reported a much lower employment rate of patients with epi-
lepsy (17%) (Djibouti 2003), while some of them reported a 
more or less similar employment rate to that in our study (65%) 
(Herodes et al 2001). In a comprehensive study that included 15 
European countries, the employment of patients ranged from 
32% in Spain to 65% in Sweden (Buck et al 1999). In the same 
study, the employment rate has significantly altered all QOLIE 
scales. Statistical analysis in the current study showed that un-
employed patients or pensioners had significantly lower scores 
of emotional state, energy/fatigue, cognitive function, socializ-
ing scales than those who were employed. QOLIE total score 
was also higher in employed patients.
Education is one of the most important predictors of quality of 
life. This is valid for overall quality of life, cognitive function, 
socializing and QOLIE-31 total score (Djibouti 2003; Loring 
et al 2004). In this study, cognitive function scale score and 
QOLIE total score were statistically significantly influenced 
by the number of years of study.
Thirty-four (30.1%) patients revealed an unsatisfactory finan-
cial situation, 37 (32.7%) an average financial situation and 
42 (37.2%) a good financial situation. Overall quality of life, 
emotional state, energy/fatigue, cognitive function, effects of 
medication, socializing and QOLIE-31 total score values were 
statistically significantly different depending on the financial 
situation of epileptic patients.
We found no significant correlations between age of onset of 
epilepsy and QOLIE scores (p>0.05). There was a negative cor-
relation of low statistical significance between disease age and 
overall quality of life, energy/fatigue, cognitive function scores 
and QOLIE-31 total score. These data are similar to those from 
other studies showing that QOLIE total score decreases with 
the increasing duration of epilepsy. In some studies, duration 
of epilepsy was an independent predictor of the score related to 
the fear of new seizures (Shetty et al 2011). However, Herodes 
et al 2001 reported lower QOLIE total scores correlated with 
reduced length of disease and significant effects on energy and 
emotional state scores.
We demonstrated the existence of a negative correlation of high 
statistical significance between the number of seizures and so-
cializing score. We found a negative correlation of average sta-
tistical significance between the number of seizures and over-
all quality of life score, cognitive function and QOLIE-31 total 
score. We found a negative correlation of low statistical signifi-
cance between the number of seizures and the fear of new sei-
zures, emotional state, energy/fatigue scores and the effects of 
medication. Other studies have reported that the high frequency 
of epileptic seizures has negatively influenced (high statistical 
significance) all QOLIE scales scores (Djibouti 2003; Loring 
et al 2004). The frequency of epileptic seizures also influenced 
the total score, the fear of new seizures, emotional state, energy/
fatigue scores in the study conducted by Piperidou et al (2008), 
Birbeck et al (2002) have highlighted the significantly improved 
quality of life in epileptic patients who no longer have seizures. 
Strauss argued that long periods without seizures are the key to 
improving quality of life in patients with epilepsy. There have 
been studies that maintained the decreasing QOLIE trend cor-
related with increased seizure frequency, but without statistical 
significance (Shetty et al 2011).
There were no differences in QOLIE scale scores between dif-
ferent types of seizures (p>0,05). There are studies reporting a 
lower QOLIE total score in patients with focal-onset seizures, 
followed by patients with generalized-onset tonic-clinical sei-
zures. Patients with myoclonic seizures had the highest total 
scores (the most affected being emotional state and effects of 
the medication scales) (Shetty et al 2011) .
There was no significant association between the etiological 
type of epilepsy and QOLIE score values (p>0.05), the results 
of the current study being in line with data obtained by various 
authors (Norsa’adah et al 2013).
The score related to the effects of medication was significantly 
higher in patients who were treated with VPA (1.9±0.7) than in 
those without this therapy (1.5±0.8), whereas patients treated 
with TPM had a lower score than those without this therapy. 
Socializing score was lower in patients treated with CBZ, PTH 
or PB than in those without this therapy. QOLIE-31 total score 
was lower in patients treated with PTH (49.1±18.6) than in those 
not taking this drug (59.8±18.8).
Conclusion 
The control of epileptic seizures and AEDs are modifiable pa-
rameters that can be taken into consideration in order to improve 
quality of life in epileptic patients.
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